Details for Patent: 9,492,449
✉ Email this page to a colleague
Which drugs does patent 9,492,449 protect, and when does it expire?
Patent 9,492,449 protects ZYDELIG and is included in one NDA.
This patent has thirty patent family members in eleven countries.
Summary for Patent: 9,492,449
| Title: | Therapies for hematologic malignancies |
| Abstract: | The invention provides methods that relate to a novel therapeutic strategy for the treatment of hematological malignancies and inflammatory diseases. In particular, the method comprises administering a compound of formula A, ##STR00001## wherein R is H, halo, or C1-C6 alkyl; R' is C1-C6 alkyl; or a pharmaceutically acceptable salt thereof; and optionally a pharmaceutically acceptable excipient; and administering at least one additional therapeutic agent. |
| Inventor(s): | Gallatin; W. Michael (Mercer Island, WA), Ulrich; Roger G. (Foster City, CA), Giese; Neill A. (San Francisco, CA), Lannutti; Brian (Seattle, WA), Miller; Langdon (Lebanon, NJ), Jahn; Thomas M. (Seattle, WA) |
| Assignee: | Gilead Calistoga LLC (Foster City, CA) |
| Application Number: | 13/417,185 |
|
Patent Claim Types: see list of patent claims | Use; Composition; |
Drugs Protected by US Patent 9,492,449
| Applicant | Tradename | Generic Name | Dosage | NDA | Approval Date | TE | Type | RLD | RS | Patent No. | Patent Expiration | Product | Substance | Delist Req. | Patented / Exclusive Use | Submissiondate |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Gilead Sciences Inc | ZYDELIG | idelalisib | TABLET;ORAL | 205858-001 | Jul 23, 2014 | RX | Yes | No | ⤷ Try a Trial | ⤷ Try a Trial | IN COMBINATION WITH RITUXIMAB, FOR THE TREATMENT OF PATIENTS WITH RELAPSED CHRONIC LYMPHOCYTIC LEUKEMIA (CLL) | ⤷ Try a Trial | ||||
| Gilead Sciences Inc | ZYDELIG | idelalisib | TABLET;ORAL | 205858-002 | Jul 23, 2014 | RX | Yes | Yes | ⤷ Try a Trial | ⤷ Try a Trial | IN COMBINATION WITH RITUXIMAB, FOR THE TREATMENT OF PATIENTS WITH RELAPSED CHRONIC LYMPHOCYTIC LEUKEMIA (CLL) | ⤷ Try a Trial | ||||
| >Applicant | >Tradename | >Generic Name | >Dosage | >NDA | >Approval Date | >TE | >Type | >RLD | >RS | >Patent No. | >Patent Expiration | >Product | >Substance | >Delist Req. | >Patented / Exclusive Use | >Submissiondate |
International Family Members for US Patent 9,492,449
| Country | Patent Number | Estimated Expiration | Supplementary Protection Certificate | SPC Country | SPC Expiration |
|---|---|---|---|---|---|
| Australia | 2009313878 | ⤷ Try a Trial | |||
| Australia | 2016201634 | ⤷ Try a Trial | |||
| Australia | 2017200837 | ⤷ Try a Trial | |||
| Australia | 2018204264 | ⤷ Try a Trial | |||
| Australia | 2018247326 | ⤷ Try a Trial | |||
| Australia | 2019213337 | ⤷ Try a Trial | |||
| >Country | >Patent Number | >Estimated Expiration | >Supplementary Protection Certificate | >SPC Country | >SPC Expiration |
